Jorge D. Reyes

Q: What Schools Are Affiliated With Jorge D. Reyes

Jorge D. Reyes is affiliated with the following schools: Stanford University, Johns Hopkins University, University of Washington, University of Pittsburgh, Harvard University

Jorge D. Reyes's AcademicInfluence.com Rankings

Jorge D. Reyes

Engineering

#6691

World Rank

#8027

Historical Rank

Biomedical Engineering

#611

World Rank

#621

Historical Rank

Architecture

#863

World Rank

#1509

Historical Rank

engineering Degrees

Jorge D. Reyes

Philosophy

#8989

World Rank

#12478

Historical Rank

Logic

#5995

World Rank

#7465

Historical Rank

philosophy Degrees

Download Badge

Engineering
Philosophy

Jorge D. Reyes's Degrees

Doctorate Medicine Harvard University
PhD Biomedical Engineering Johns Hopkins University

Why Is Jorge D. Reyes Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Jorge D. Reyes is an American surgeon and academic. Reyes is focused on enhancing organ transplant options and availability, improving outcomes post-transplant, and minimizing immunosuppression and tolerance induction. Reyes is currently the Roger K. Giesecke Distinguished Chair in Transplant Surgery at the University of Washington.

(See a Problem?)

Jorge D. Reyes's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Long-Term Survival After Liver Transplantation in 4,000 Consecutive Patients at a Single Center (2000) (489)
2003 Report of the Intestine Transplant Registry: A New Era Has Dawned (2005) (441)
The association of Epstein-Barr virus with smooth-muscle tumors occurring after organ transplantation. (1995) (435)
Weaning of immunosuppression in liver transplant recipients. (1997) (413)
Clinical Intestinal Transplantation: A Decade of Experience at a Single Center (2001) (340)
Indications for pediatric intestinal transplantation: A position paper of the American Society of Transplantation (2001) (331)
Use of quantitative competitive PCR to measure Epstein-Barr virus genome load in the peripheral blood of pediatric transplant patients with lymphoproliferative disorders (1997) (298)
The biopsied donor liver: Incorporating macrosteatosis into high‐risk donor assessment (2010) (284)
D‐MELD, a Simple Predictor of Post Liver Transplant Mortality for Optimization of Donor/Recipient Matching (2009) (269)
Outcome Analysis of 71 Clinical Intestinal Transplantations (1995) (255)
Pathology of human intestinal transplantation. (1996) (228)
Impact of Cytomegalovirus in Organ Transplant Recipients in the Era of Antiviral Prophylaxis (2006) (219)
Liver transplantation for “very early” intrahepatic cholangiocarcinoma: International retrospective study supporting a prospective assessment (2016) (217)
Ischemic cholangiopathy following liver transplantation from donation after cardiac death donors (2008) (216)
Current status of intestinal transplantation in children. (1998) (214)
Intestinal transplantation in composite visceral grafts or alone. (1992) (212)
Posttransplant Lymphoproliferative Disorders in Liver Transplantation: A 20-Year Experience (2002) (205)
Comparative incidence of de novo nonlymphoid malignancies after liver transplantation under tacrolimus using surveillance epidemiologic end result data. (1998) (192)
Pregnancy after liver transplantation with tacrolimus immunosuppression: a single center’s experience update at 13 years1 (2003) (189)
Histological criteria for the identification of acute cellular rejection in human small bowel allografts: results of the pathology workshop at the VIII International Small Bowel Transplant Symposium. (2004) (179)
Transplantation of human hepatocytes. (1997) (174)
Serial measurement of Epstein-Barr viral load in peripheral blood in pediatric liver transplant recipients during treatment for posttransplant lymphoproliferative disease. (1998) (169)
Dendritic Cell Subset Ratio in Peripheral Blood Correlates with Successful Withdrawal of Immunosuppression in Liver Transplant Patients (2003) (161)
Logistics and Technique for Procurement of Intestinal, Pancreatic, and Hepatic Grafts From the Same Donor (2000) (161)
Liver transplantation and chemotherapy for hepatoblastoma and hepatocellular cancer in childhood and adolescence. (2000) (160)
Liver transplantation at the extremes of the body mass index (2009) (155)
Weaning Of Immunosuppression In Long‐Term Liver Transplant Recipients (1995) (150)
CADAVERIC SMALL BOWEL AND SMALL BOWEL‐LIVER TRANSPLANTATION IN HUMANS 1,2 (1992) (149)
Epstein–Barr virus load monitoring: its role in the prevention and management of post‐transplant lymphoproliferative disease (2001) (149)
Factors impacting the survival of children with intestinal failure referred for intestinal transplantation. (1999) (146)
Clinical intestinal transplantation. (1993) (146)
Hepatic hemangioendothelioma: clinical experience and management strategy. (1999) (141)
Clinical intestinal transplantation: new perspectives and immunologic considerations. (1998) (139)
Three years clinical experience with intestinal transplantation. (1994) (137)
What have we learned about primary liver transplantation under tacrolimus immunosuppression? Long-term follow-up of the first 1000 patients. (1999) (134)
Aging of Liver Transplant Registrants and Recipients: Trends and Impact on Waitlist Outcomes, Post-Transplantation Outcomes, and Transplant-Related Survival Benefit. (2016) (128)
Pediatric liver transplantation. A single center experience spanning 20 years. (2002) (127)
The management of Epstein–Barr virus associated post‐transplant lymphoproliferative disorders in pediatric solid‐organ transplant recipients (1999) (123)
Graft Versus Host Disease in Intestinal Transplantation (2004) (121)
Epstein-Barr virus infections in children after transplantation of the small intestine. (1998) (120)
WEANING OF IMMUNOSUPPRESSION IN LONG-TERM LIVER TRANSPLANT RECIPIENTS (1995) (114)
BACTERIAL TRANSLOCATION IN CLINICAL INTESTINAL TRANSPLANTATION (2000) (113)
CMV‐IVIG for Prevention of Epstein Barr Virus Disease and Posttransplant Lymphoproliferative Disease in Pediatric Liver Transplant Recipients (2006) (112)
Ensuring Equity, Diversity, and Inclusion in Academic Surgery: An American Surgical Association White Paper (2018) (111)
Percutaneous transluminal angioplasty of venous anastomotic stenoses complicating liver transplantation: intermediate-term results. (1994) (111)
Comparison of intravenous ganciclovir followed by oral acyclovir with intravenous ganciclovir alone for prevention of cytomegalovirus and Epstein-Barr virus disease after liver transplantation in children. (1997) (109)
SMALL INTESTINAL TRANSPLANTATION IN HUMANS WITH OR WITHOUT THE COLON1,2 (1994) (108)
PREDICTIVE NEGATIVE VALUE OF PERSISTENT LOW EPSTEIN-BARR VIRUS VIRAL LOAD AFTER INTESTINAL TRANSPLANTATION IN CHILDREN12 (2000) (107)
Split-liver transplantation: a comparison of ex vivo and in situ techniques. (2000) (105)
Liver transplantation for polycystic liver disease. (1990) (105)
Resection, including transplantation, for hepatoblastoma and hepatocellular carcinoma: impact on survival. (1992) (103)
Neonatal hemochromatosis: outcomes of pharmacologic and surgical therapies. (1998) (103)
Management of posttransplant lymphoproliferative disease in pediatric liver transplant recipients receiving primary tacrolimus (FK506) therapy. (1998) (102)
Dendritic Cell Subset Ratio in Tolerant, Weaning and Non‐Tolerant Liver Recipients Is Not Affected by Extent of Immunosuppression (2004) (101)
Intestinal Transplantation under Tacrolimus Monotherapy after Perioperative Lymphoid Depletion with Rabbit Anti‐Thymocyte Globulin (Thymoglobulin®) (2005) (99)
Frequent achievement of a drug-free state after orthotopic liver transplantation. (1993) (96)
Thrombotic and nonthrombotic hepatic artery complications in adults and children following primary liver transplantation with long‐term follow‐up in 1000 consecutive patients * (2006) (92)
The role of antiviral and immunoglobulin therapy in the prevention of Epstein–Barr virus infection and post‐transplant lymphoproliferative disease following solid organ transplantation (2001) (91)
Liver transplantation for Alagille's syndrome. (1993) (89)
Epstein-Barr virus gene expression in the peripheral blood of transplant recipients with persistent circulating virus loads. (2000) (88)
Pediatric intestinal transplantation: Historical notes, principles and controversies (2002) (86)
COMPARATIVE LONG-TERM EVALUATION OF TACROLIMUS AND CYCLOSPORINE IN PEDIATRIC LIVER TRANSPLANTATION (2000) (86)
Current status of intestinal transplantation. (1994) (85)
Long-term survival after liver transplantation in 4000 consecutive patients at a single center (2000) (85)
Intestinal transplantation: a coming of age. (2002) (85)
Evolution of clinical intestinal transplantation: improved outcome and cost effectiveness. (1999) (85)
Liver transplantation in patients over sixty years of age. (2001) (83)
Sirolimus for rescue and primary immunosuppression in transplanted children receiving tacrolimus. (2001) (79)
Intestinal transplantation in children with chronic intestinal pseudo-obstruction (1999) (79)
Incidence and risk factors associated with the development of cytomegalovirus disease after intestinal transplantation. (1995) (78)
Hemophagocytic Syndrome Presenting as Acute Hepatic Failure in Two Infants: Clinical Overlap with Neonatal Hemochromatosis (1999) (78)
Outcomes of immunosuppression minimization and withdrawal early after liver transplantation (2018) (78)
Pediatric transplantation, 1994–2003 (2005) (78)
Liver transplantation in children with cystic fibrosis: a long-term longitudinal review of a single center's experience. (2003) (77)
Pharmacokinetics of Sirolimus and Tacrolimus in Pediatric Transplant Patients (2004) (76)
Abdominal Multivisceral Transplantation (1995) (71)
Composite liver--small bowel allografts with preservation of donor duodenum and hepatic biliary system in children. (2000) (70)
Cryptococcal meningitis after liver transplantation. (1996) (68)
Comparative study of cyclosporine and FK 506 dosage requirements in adult and pediatric orthotopic liver transplant patients. (1991) (68)
The role of Foxp3+ regulatory T cells in liver transplant tolerance. (2006) (67)
Epstein Barr virus associated posttransplant lymphoproliferative disease after intestinal transplantation. (1996) (66)
Use of indium-111-labeled hepatocytes to determine the biodistribution of transplanted hepatocytes through portal vein infusion. (2000) (66)
Logistics and technique for combined hepatic-intestinal retrieval. (1992) (65)
Outcomes in Children After Intestinal Transplant (2010) (64)
Primary tacrolimus (FK506) therapy and the long‐term risk of post‐transplant lymphoproliferative disease in pediatric liver transplant recipients (2001) (63)
Causes of retransplantation after primary liver transplantation in 4000 consecutive patients: 2 to 19 years follow-up. (2001) (63)
PARVOVIRUS B19 INFECTION IN PEDIATRIC TRANSPLANT PATIENTS (1993) (63)
IMMUNOMODULATION FOR INTESTINAL TRANSPLANTATION BY ALLOGRAFT IRRADIATION, ADJUNCT DONOR BONE MARROW INFUSION, OR BOTH1 (2000) (61)
Bacterial translocation in clinical intestinal transplantation. (2001) (61)
Use of SARS-CoV-2-infected deceased organ donors: Should we always “just say no?” (2020) (61)
Intrahepatic chemoembolization in unresectable pediatric liver malignancies (2000) (60)
Impact of Portable Normothermic Blood-Based Machine Perfusion on Outcomes of Liver Transplant (2022) (60)
Temporary end to side portacaval shunt in orthotopic hepatic transplantation in humans. (1993) (59)
Identifying risk for recurrent hepatocellular carcinoma after liver transplantation: Implications for surveillance studies and new adjuvant therapies (2008) (58)
Long-term nutritional outcome after pediatric intestinal transplantation. (2002) (57)
The experience of a regional pediatric intestinal failure program: Successful outcomes from intestinal rehabilitation. (2010) (57)
Long-term results after conversion from cyclosporine to tacrolimus in pediatric liver transplantation for acute and chronic rejection. (2000) (57)
Pathology of intestinal transplantation in children. (1995) (56)
Reduced-size orthotopic composite liver-intestinal allograft. (1998) (56)
Endoscopies in Pediatric Small Intestinal Transplant Recipients: Five Years Experience (1998) (56)
Clinical factors predicting readmission after orthotopic liver transplantation (2012) (56)
Chronic Rejection of Small Bowel Grafts: Pediatric and Adult Study of Risk Factors and Morphologic Progression (2003) (54)
Hyperbaric oxygen therapy for hepatic artery thrombosis after liver transplantation in children. (1999) (53)
The efficacy of daclizumab for intestinal transplantation: preliminary report. (1999) (53)
Clinical intestinal transplantation: a decade of a single center experience (2001) (52)
Causes of mortality beyond 1 year after primary pediatric liver transplant under tacrolimus1 (2002) (52)
Bacteremia after intestinal transplantation in children correlates temporally with rejection or gastrointestinal lymphoproliferative disease. (2000) (52)
Cytomegalovirus infection after intestinal transplantation in children. (1997) (51)
Analysis of patients with longitudinal intestinal lengthening procedure referred for intestinal transplantation. (2001) (51)
Two-year experience with FK 506 in pediatric patients. (1993) (49)
Intraoperative portal vein blood flow predicts allograft and patient survival following liver transplantation. (2010) (49)
Risks and benefits of weaning immunosuppression in liver transplant recipients: long-term follow-up. (1997) (49)
The role of viral load in the diagnosis, management, and possible prevention of Epstein-barr virus–associated posttransplant lymphoproliferative disease following solid organ transplantation (1999) (49)
Orthotopic liver transplantation for ornithine transcarbamylase deficiency with hyperammonemic encephalopathy. (1995) (47)
Recipient and donor factors influence the incidence of graft‐vs.‐host disease in liver transplant patients (2007) (46)
Noncompliance after pediatric liver transplantation. (1999) (45)
Graft-versus-host disease after liver and small bowel transplantation in a child. (1997) (44)
Kava-induced fulminant hepatic failure. (2002) (44)
Mycobacterium tuberculosis after liver transplantation: Management and guidelines for prevention (1992) (44)
Liver transplantation under tacrolimus in infants, children, adults, and seniors: long-term results, survival, and adverse events in 1000 consecutive patients. (1998) (43)
Clinical features of nosocomial rotavirus infection in pediatric liver transplant recipients. (1995) (43)
Anti-CD25 mAb administration prevents spontaneous liver transplant tolerance. (2006) (43)
Use of quantitative PCR to predict onset of Epstein-Barr viral infection and post-transplant lymphoproliferative disease after intestinal transplantation in children. (1996) (43)
Cytokine gene polymorphisms in children successfully withdrawn from immunosuppression after liver transplantation. (2002) (43)
Posttransplant lymphoproliferative disorders occurring under primary FK 506 immunosuppression. (1991) (43)
Monitoring and treatment of intestinal allograft rejection in humans. (1993) (42)
Exfoliative rejection after intestinal transplantation in children (2003) (42)
Infusion of donor leukocytes to induce tolerance in organ allograft recipients (1999) (42)
Monitoring the patient off immunosuppression. Conceptual framework for a proposed tolerance assay study in liver transplant recipients. (2001) (42)
Expessive dysphasia possibly related to FK506 in two liver transplant recipients (1990) (41)
The impact of positive T-cell lymphocytotoxic crossmatch on intestinal allograft rejection and survival. (2000) (41)
Outcome of children with cerebral edema caused by fulminant hepatic failure. (1998) (41)
Cryptosporidial infections after solid organ transplantation in children (2000) (41)
Experience with posttransplant lymphoproliferative disorders in solid organ transplant recipients. (1992) (40)
Detection of Epstein-Barr Virus Genomes in Peripheral Blood B Cells from Solid-Organ Transplant Recipients by Fluorescence In Situ Hybridization (2002) (40)
Posttransplant lymphoproliferative disorders in small bowel allograft recipients. (2000) (40)
Pediatric liver transplantation for hepatocellular cancer and rare liver malignancies: US multicenter and single‐center experience (1981‐2015) (2017) (39)
Evolutionary experience with immunosuppression in pediatric intestinal transplantation. (2005) (39)
Liver transplant recipients weaned off immunosuppression lack circulating donor-specific antibodies. (2010) (38)
Nutritional management of intestinal transplant recipients. (1993) (38)
Intestinal motility after small bowel transplantation. (1998) (37)
Management of intestinal transplantation in humans. (1992) (37)
Intestinal transplantation for total/near-total aganglionosis and intestinal pseudo-obstruction. (2004) (36)
PD-L1 signal on liver dendritic cells is critical for Foxp3(+)CD4(+)CD25(+) Treg and liver tolerance induction in mice. (2013) (36)
Early tolerance in pediatric liver allograft recipients. (1994) (36)
Management of hepatic venous obstruction after split‐liver transplantation (2000) (36)
Causes of death after liver transplantation in 4000 consecutive patients: 2 to 19 year follow-up. (2001) (36)
Internal hernia and volvulus of the small bowel following liver transplantation (1997) (35)
Risk stratification of kidneys from donation after cardiac death donors and the utility of machine perfusion (2011) (35)
PD-L1/PD-1 Signal Deficiency Promotes Allogeneic Immune Responses and Accelerates Heart Allograft Rejection (2008) (35)
One thousand consecutive primary orthotopic liver transplants under FK 506: survival and adverse events. (1995) (34)
Use of FK 506 in pediatric patients. (1991) (34)
FK 506 versus cyclosporine in pediatric liver transplantation. (1991) (34)
The absence of chronic rejection in pediatric primary liver transplant patients who are maintained on tacrolimus-based immunosuppression: a long-term analysis1 (2003) (33)
Intestinal transplantation for children with short bowel syndrome. (2001) (33)
FK506 (tacrolimus) in the treatment of steroid-resistant acute graft-versus-host disease in children undergoing bone marrow transplantation. (1995) (32)
Intestinal transplantation in children under FK 506 immunosuppression. (1993) (31)
A Randomized Clinical Trial Testing the Anti-Inflammatory Effects of Preemptive Inhaled Nitric Oxide in Human Liver Transplantation (2014) (31)
Piggyback orthotopic intestinal transplantation. (1993) (31)
EBV-specific memory CD8+ T cell phenotype and function in stable solid organ transplant patients. (2005) (30)
An analysis of pretransplantation variables associated with long-term allograft outcome in pediatric liver transplant recipients receiving primary tacrolimus (FK506) therapy. (1998) (30)
DE NOVO MALIGNANCIES AFTER INTESTINAL AND MULTIVISCERAL TRANSPLANTATION (2004) (30)
FK 506-associated diabetes mellitus in the pediatric transplant population is a rare complication. (1991) (29)
Tacrolimus for primary liver transplantation: 12 to 15 years actual follow-up with safety profile. (2005) (28)
Ex Vivo Priming of Naïve T Cells Into EBV‐Specific Th1/Tc1 Effector Cells by Mature Autologous DC Loaded with Apoptotic/Necrotic LCL (2003) (28)
Infectious complications of pediatric liver transplantation under FK 506. (1991) (27)
Imaging in liver transplantation. (1996) (27)
Impact of Cold Ischemia Time on Outcomes of Liver Transplantation: A Single Center Experience. (2016) (26)
Unique aspects of the infectious complications of intestinal transplantation (1999) (26)
Arterioportal fistula following liver biopsy. Three cases occurring in liver transplant recipients. (1995) (26)
New strategies in the prevention and management of Epstein-Barr virus infection and posttransplant lymphoproliferative disease following solid organ transplantation (1998) (26)
Lymphoproliferative disease after intestinal transplantation under primary FK 506 immunosuppression. (1994) (25)
Preliminary immunosuppression withdrawal strategies with sirolimus in children with liver transplants. (2002) (25)
The neuropathology of intestinal failure and small bowel transplantation (1999) (25)
Should liver transplantation in patients with model for end‐stage liver disease scores ≤ 14 be avoided? A decision analysis approach (2009) (25)
Reasons why some children receiving tacrolimus therapy require steroids more than 5 years post liver transplantation (2001) (25)
Ultrashort Bowel Syndrome in Children (2013) (25)
Infectious complications after human small bowel transplantation. (1992) (25)
Changing the paradigm of organ utilization from PHS increased‐risk donors: an opportunity whose time has come? (2015) (25)
RESULTS OF SIMULTANEOUS AND SEQUENTIAL PEDIATRIC LIVER AND KIDNEY TRANSPLANTATION (2001) (24)
Clinical Impact and Risk Factors of Portal Vein Thrombosis for Patients on Wait List for Liver Transplant. (2018) (24)
Intestinal transplantation for patients with short gut syndrome and hypercoagulable states. (2000) (24)
Clinical small bowel or small bowel plus liver transplantation under FK 506. (1991) (24)
Anatomic variability of rejection in intestinal allografts after pediatric intestinal transplantation. (1998) (23)
Expressive dysphasia possibly related to FK506 in two liver transplant recipients. (1990) (23)
Factors associated with mortality within 24h of liver transplantation: An updated analysis of 65,308 adult liver transplant recipients between 2002 and 2013. (2018) (23)
DENDRITIC CELL SUBSET RATIO IN TOLERANT, WEANING, AND NON-TOLERANT LIVER RECIPIENTS IS NOT AFFECTED BY EXTENT OF IMMUNOSUPPRESSION (2004) (23)
Impact of obesity on children undergoing liver transplantation (2010) (22)
Transhepatic insertion of vascular dialysis catheters in children: a safe, life-prolonging procedure (1999) (22)
Intestinal transplantation and bacterial overgrowth in humans. (1994) (22)
Pediatric liver transplantation in 808 consecutive children: 20-years experience from a single center. (2002) (22)
Central venous recanalization in patients with short gut syndrome: restoration of candidacy for intestinal and multivisceral transplantation. (2005) (22)
Differential Rates of Ischemic Cholangiopathy and Graft Survival Associated With Induction Therapy in DCD Liver Transplantation (2015) (22)
Impact of locoregional therapy and alpha‐fetoprotein on outcomes in transplantation for liver cancer: a UNOS Region 6 pooled analysis (2013) (22)
Outcomes of Simultaneous Liver and Kidney Transplantation in Relation to a High Level of Preformed Donor-Specific Antibodies (2013) (22)
Intestinal transplantation in humans under FK 506. (1993) (21)
Pharmacodynamics of sirolimus in transplanted children receiving tacrolimus. (2002) (21)
Liver transplantation for neonatal hepatitis as compared to the other two leading indications for liver transplantation in children. (1994) (21)
Hepatic artery thrombosis and liver malignancy in pediatric liver transplantation. (2012) (21)
Role of endoscopy following small intestinal transplantation in children. (1994) (20)
Emerging evidence to support not always “just saying no” to SARS-CoV-2 positive donors (2020) (20)
The role of portosystemic shunting in children in the transplant era. (1999) (20)
Intravenous, oral pharmacokinetics, and oral dosing of FK 506 in small bowel transplant patients. (1992) (20)
Pediatric Intestinal Transplantation: The Resected Allograft (2002) (20)
Small bowel and liver/small bowel transplantation in children. (1993) (20)
Clinical intestinal transplantation. (1996) (20)
Clinical intestinal transplantation: focus on complications. (1992) (20)
Use of intrahepatic chemotherapy to treat advanced pediatric hepatic malignancies. (2000) (19)
Evolution of surgical techniques in clinical intestinal transplantation. (1994) (19)
Augmentation of chimerism with perioperative donor bone marrow infusion in organ transplant recipients: a 44 month follow-up. (1997) (19)
Case report of combined pediatric heart-lung-liver transplantation. (2002) (19)
Donor-Recipient Size Matching Influences Early But Not Late Graft Function After Pediatric En-Bloc Kidney Transplantation (2010) (19)
Size mismatch in deceased donor liver transplantation and its impact on graft survival (2019) (19)
Intestinal transplantation at the University of Pittsburgh. (1994) (18)
The use of cultured hepatocyte infusion via the portal vein for the treatment of ornithine transcarbamoylase deficiency by transplantation of enzymatically competent ABO/Rh-matched cell (1996) (18)
Current management of portal hypertension with liver transplantation. (1992) (18)
Intestinal transplantation at the University of Pittsburgh: six-year experience. (1997) (18)
Early infectious complications of liver-intestinal transplantation in children: preliminary analysis. (1994) (18)
The use of clonidine for the treatment of high intestinal output following small bowel transplantation. (1997) (18)
Endorectal pull-through of transplanted colon as part of intestinal transplantation. (1995) (17)
Nutritional monitoring of pediatric intestinal transplant recipients. (1998) (17)
Intestinal transplantation: an unexpected journey. Robert E. Gross Lecture. (2014) (17)
Living liver donation improves patient and graft survival in the pediatric population (2018) (16)
Intestinal transplantation: 4-year experience. (1995) (16)
Use of an automated clinical management system improves outpatient immunosuppressive care following liver transplantation (2010) (16)
Liver and intestinal transplantation in a child with cystic fibrosis: A case report (2003) (16)
Intestinal transplantation in children: five-year experience. (1996) (16)
Temporary end-to-side portocaval shunt in orthotopic liver transplantation (1993) (16)
Randomized trial of ganciclovir followed by high-dose oral acyclovir vs ganciclovir alone in the prevention of cytomegalovirus disease in pediatric liver transplant recipients: preliminary analysis. (1994) (16)
FK 506 in small bowel transplant recipients: pharmacokinetics and dosing. (1994) (15)
Results of simultaneous and sequential pediatric liver and kidney transplantation. (1998) (14)
Rituximab in the treatment of pediatric small bowel transplant patients with posttransplant lymphoproliferative disorder unresponsive to standard treatment. (2002) (14)
Deceased Donor Organ Transplantation Performed in the United States for Noncitizens and Nonresidents (2018) (14)
Arterioportal fistula following liver biopsy (1995) (14)
Augmentation of Type-1 Polarizing Ability of Monocyte-Derived Dendritic Cells from Chronically Immunosuppressed Organ-Transplant Recipients (2005) (13)
Donor Age Still Matters in Liver Transplant: Results From the United Network for Organ Sharing-Scientific Registry of Transplant Recipients Database. (2017) (13)
Serum growth factors and growth indices pre- and post-pediatric intestinal transplantation. (2003) (13)
The impact of consecutive operations on survival after liver transplantation (2009) (13)
Intestinal transplantation in 31 adults. (1996) (13)
Sclerosing peritonitis after intestinal transplantation in children (2005) (13)
New Evidence Supporting Increased Use of Split Liver Transplantation (2020) (13)
Two year experience with FK506 in pediatric patients (1993) (13)
Identifying the futile pediatric liver re‐transplant in the PELD era (2010) (13)
Clinical intestinal transplantation in 1998: Pittsburgh experience. (1999) (12)
Almost total absence of chronic rejection in primary pediatric liver transplantation under tacrolimus. (2002) (12)
gammadeltaT cells are involved in liver transplant tolerance. (2009) (12)
Adjuvant bone marrow infusion in clinical organ transplant recipients. (1998) (12)
Enteral formula use in children after small bowel transplant. (2002) (12)
Rejection of human intestinal allografts: alone or in combination with the liver. (1994) (12)
A critical analysis to a critical analysis: Breaking the circle of organ allocation in the United States (2005) (12)
Conversion from Cyclosporin to Tacrolimus in Paediatric Liver Transplant Recipients (2001) (11)
The long-term efficacy of multivisceral transplantation. (2000) (11)
Review Article: Small Intestinal Transplantation for Irreversible Intestinal Failure in Children (1997) (11)
Natural history of Epstein-Barr viral load in peripheral blood of pediatric liver transplant recipients during treatment for posttransplant lymphoproliferative disorder. (1998) (11)
Severe exfoliative rejection after intestinal transplantation in children. (1996) (11)
Outcomes in children with intestinal failure following listing for intestinal transplant. (2010) (11)
A data‐driven patient blood management strategy in liver transplantation (2018) (11)
Use of the D-xylose absorption test in monitoring intestinal allografts. (1994) (11)
Nutrition Management in Pediatric Small Bowel Transplant (1999) (11)
Molecular Signatures of Recurrent Hepatocellular Carcinoma Secondary to Hepatitis C Virus following Liver Transplantation (2013) (11)
Pancreatitis after liver transplantation in children: a single-center experience (2003) (10)
Pediatric Liver Transplantation (1993) (10)
Technical aspects of intestinal transplantation. (1993) (10)
Monitoring the patient off immunosuppression (2001) (10)
Pancreatic transplantation at the University of Pittsburgh. (2004) (10)
Hyperammonemia syndrome due to Ureaplasma infection after liver‐kidney transplant (2020) (10)
Lymphocyte subsets may discern treatment effects in children and young adults with post‐transplant lymphoproliferative disorder (2003) (10)
Immunomodulation of intestinal transplant with allograft irradiation and simultaneous donor bone marrow infusion. (1998) (10)
Rubella infection after orthotopic liver transplantation. (1994) (9)
Phase I adjuvant trial of sorafenib in patients with hepatocellular carcinoma after orthotopic liver transplantation. (2013) (9)
Lymphocyte trafficking using in situ hybridization and physioanatomy of the intestinal immune system after human small bowel transplantation. (1992) (9)
Histologic spectrum of acute cellular rejection in human intestinal allografts. (1996) (9)
A technique for distal splenoadrenal shunting in pediatric portal hypertension. (1998) (9)
The Impact of Increased Allocation Priority for Children Awaiting Liver Transplant: A Liver Simulated Allocation Model (LSAM) Analysis (2019) (9)
Living Donation Versus Donation After Circulatory Death Liver Transplantation for Low Model for End‐Stage Liver Disease Recipients (2019) (9)
Intestinal transplantation in children (1999) (8)
Stress (Takotsubo) Cardiomyopathy During Liver Transplantation: Case Study and Literature Review. (2018) (8)
Intestinal transplantation with or without other abdominal organs: nutritional and dietary management of 50 patients. (1994) (8)
What's new in pediatric organ transplantation. (1999) (8)
Organ donation from children with meningitis. (2003) (8)
Liver and small bowel transplantation for short gut syndrome in a child (1991) (8)
Factors associated with recurrent cytomegalovirus disease after small bowel transplantation. (1994) (7)
Comparison of Preemptive Therapy and Antiviral Prophylaxis for Prevention of Cytomegalovirus in Seropositive Liver Transplant Recipients (2017) (7)
Immunosuppressant strategies for intestinal transplantation: a review of a tolerogenic regimen. (2005) (7)
Abnormal gastric emptying after intestinal transplantation. (1994) (7)
Influence of donor criteria on early outcome after intestinal transplantation. (1997) (7)
Improving results of pediatric renal transplantation. (1994) (7)
Successful liver transplantation for isoniazid-induced hepatic failure--a case report. (1994) (7)
A high plasma: red blood cell transfusion ratio during liver transplantation is associated with decreased blood utilization (2018) (7)
Candidates for intestinal transplantation and possible indicators of outcome. (1994) (6)
Ulcerative colitis after liver transplant and immunosuppression. (1999) (6)
Intestinal retransplantation. (1996) (6)
Incidence Of End-Stage Renal Failure Amongst Long-term Survival Of Primary Liver Transplant Recipients Under Tacrolimus: Adults and Children (1998) (6)
Is MELD score failing patients with liver disease and hepatorenal syndrome? (2016) (6)
Histologic monitoring of human small bowel allografts with clinical correlation. (1992) (6)
Detrimental graft survival of size‐mismatched graft for high model for end‐stage liver disease recipients in liver transplantation (2016) (6)
Liver transplantation for growing teratoma syndrome: Report of a case (2003) (6)
Intestinal and multiple organ transplantation (1995) (6)
Late severe rejection of intestinal allografts: risks and survival outcome. (2001) (6)
Immune modulation in organ allograft recipients by single or multiple donor bone marrow infusions. (1999) (6)
Eating difficulties in the pediatric small bowel recipient: the role of the nutritional management team. (1994) (6)
The current status of hepatic transplantation at the University of Pittsburgh. (1995) (6)
Long Term Management of Liver Transplant Rejection in Children (2000) (5)
Isolated intestinal versus composite visceral allografts: causes of graft failure. (2000) (5)
Intestinal Failure and Visceral Transplantation: A New Era of Colossal Achievement (2004) (5)
Gastrointestinal posttransplant lymphoproliferative disease in children after small intestinal transplantation. (1996) (5)
Concomitant infusion of unmodified donor bone marrow into unconditioned recipients of intestinal allografts. (1996) (5)
Livers From Pediatric Donation After Circulatory Death Donors Represent a Viable and Underutilized Source of Allograft (2020) (5)
Improved survival with cytomegalovirus infection after intestinal transplantation in children. (1996) (5)
Do funding sources influence long‐term patient survival in pediatric liver transplantation? (2020) (4)
Progression of Hepatic Adenoma to Carcinoma in the Setting of Hepatoportal Sclerosis in HIV Patient: Case Report and Review of the Literature (2016) (4)
Post-transplant lymphoproliferative disorders (PTLD) in liver transplantation (LTX): A twenty year experience (2002) (4)
Early clinical and histologic viability of human liver-small intestinal allografts after implantation. (1994) (4)
Splenic Subcapsular Hematoma After Endoscopic Retrograde Cholangiopancreatography in a Liver Transplant Recipient: Case Report and Literature Review. (2017) (4)
Pediatric End-stage Liver Disease Scores as a Method of Assessing Mortality Risk or Prioritization to Transplantability: Let Us Save the Children. (2018) (4)
Superior Patient and Graft Survival in Adult Liver Transplant with Rabbit Antithymocyte Globulin Induction: Experience with 595 Patients. (2017) (4)
Pathologic analysis of recurrent posttransplant lymphoproliferative disorders. (1995) (4)
Association of Donor and Recipient Cytomegalovirus Serostatus on Graft and Patient Survival in Liver Transplant Recipients (2021) (4)
The HALOS‐ND model: a step in the journey of predicting hospital length of stay after liver transplantation (2013) (4)
Patient profile and candidacy for intestinal transplantation at the University of Pittsburgh. (2002) (4)
Effect of CMV serology on outcome after clinical intestinal transplantation. (1996) (4)
Hepatic and intestinal transplantation at the University of Pittsburgh. (1998) (3)
WHY SOME CHILDREN ARE STILL ON STEROID BEYOND FIVE YEARS POST LIVER TRANSPLANTATION UNDER TACROLIMUS (1999) (3)
Risks and Epidemiology of Infections After Intestinal Transplantation (2016) (3)
Pediatric transplantation. (1999) (3)
Serum alkaline phosphatase and bilirubin are early surrogate markers for ischemic cholangiopathy and graft failure in liver transplantation from donation after circulatory death. (2015) (3)
Transplantation of the small bowel and other abdominal organs in humans (1994) (3)
Basic considerations for the procurement of intestinal grafts. (1994) (3)
What Have We Learned About Primary Liver Transplantation Under Tacrolimus Immunosuppression? (1999) (3)
Primary Liver Transplantation in children under Tacrolimus:3 to 8 years actual follow-up (1998) (3)
Predictive Negative Value (PNV) of Persistent Low EBV Viral Loads After Intestinal Transplantation (ITx) in Children (1999) (3)
Carcinoma of donor origin after liver‐intestine transplantation in a child (2005) (3)
Machine Perfusion Decreases Delayed Graft Function in Donor Grafts With High Kidney Donor Profile Index. (2020) (3)
Immunoreactive trypsinogen levels in pediatric patients with intestinal failure awaiting intestinal transplantation (1999) (3)
INCIDENCE OF POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER IN ADULTS AND CHILDREN: CONSECUTIVE 1000 PRIMARY LIVER TRANSPLANT RECIPIENTS UNDER TACROLIMUS. (1999) (3)
Chronic Moderate Aortic Regurgitation in Liver Transplantation: Prevalence, Perioperative Management, and Short-Term Outcomes. (2019) (3)
The impact of public health service increased risk donors in pediatric liver transplantation (2020) (3)
Association of Body Surface Area With Access to Deceased Donor Liver Transplant and Novel Allocation Policies. (2023) (2)
A NEW TOLERGENIC IMMUNOSUPPRESSIVE STRATEGY FOR HUMAN INTESTINAL TRANSPLANTATION (2004) (2)
Intestinal Transplantation in Children with Intestinal Failure (2011) (2)
Modified temporary end‐to‐side portocaval shunt in liver and small bowel transplantation (2001) (2)
An isolated complete intestinal transplantation in an adult: A complicated postoperative course (1992) (2)
Impact of Donor and Recipient Clinical Characteristics and Hepatic Histology on Steatosis/Fibrosis Following Liver Transplantation (2021) (2)
Monitoring of intestinal myoelectrical activity after isolated small bowel transplantation in FK 506 immunosuppressed pigs. (1994) (2)
Detection of rejection in pediatric intestinal transplant recipients varies by sites sampled (1995) (2)
Immunoreactivity of T lymphocytes propagated from biopsies of human cadaveric small intestine allografts: a serial study of four patients. (1992) (2)
Landscape of Kidney Transplantation in Patients With Compensated Liver Disease: Results of a Survey of Transplant Surgeons in the United States. (2016) (2)
BACTERIAL TRANSLOCATION IN INTESTINAL TRANSPLANT RECIPIENTS (1999) (2)
RABBIT ANTI-THYMOCYTE (RATG) PRECONDITIONING AND INDUCTION FOR PEDAITRIC INTESTINE TRANSPLANTATION (2004) (2)
D-MELD risk capping improves post-transplant and overall mortality under markov microsimulation. (2014) (2)
WEANING OF IMMUNOSUPPRESSION IN LIVER TRANSPLANT RECIPIENTS 1,2 (2010) (2)
Conversion of pediatric liver allograft recipients from Cyclosporin to Tacrolimus based immunosuppression: 4 to 8 years follow-up. (1998) (2)
Expressive dysplasia possibly related to FK 506 in 2 liver transplantation recipients (1990) (2)
IMMUNOLOGIC ASSAYS IN PATIENTS SUCCESSFULLY WITHDRAWN FROM IMMUNOSUPPRESSION (IS) AFTER LIVER TRANSPLANTATION (LTX) (2004) (2)
The use of hepatitis B core antibody-positive donor livers does not appear to have a deleterious effect on graft survival in liver transplantation for hepatitis C. (2010) (2)
Endoscopies in pediatric intestinal transplantation: Five year experience (1996) (2)
Acute Graft‐Versus‐Host Disease After Orthotopic Liver Transplantation: Predicting This Rare Complication Using Machine Learning (2021) (2)
Intestinal transplantation in children after primary liver transplantation. (1998) (2)
Transient Posttransplant Graft-versus-Host Lymphadenopathy (2004) (2)
Principles of transplantation (2006) (1)
NKT Cells in the Liver are Important for Peripheral Tolerance Induction (2016) (1)
Post-operative care of small bowel transplant recipients (1993) (1)
Chapter 45 – Principles of Transplantation (2012) (1)
Use of FK 506 in the treatment of liver allograft rejection (1991) (1)
LIVER TRANSPLANTATION IN CHILDREN WITH CIRRHOSIS AND HEPATOPULMONARY SYNDROME (1995) (1)
ADJUVANT DONOR BONE MARROW INFUSION IN ORGAN TRANSPLANT RECIPIENTS IS ASSOCIATED WITH REDUCED INCIDENCE OF ACUTE AND CHRONIC REJECTION (1999) (1)
RAPAMYCIN RESCUE IN PEDIATRIC LIVER RECIPIENTS WITH TACROLIMUS TOXICITY. A PRELIMINARY EFFECT: CONCENTRATION ANALYSIS.: Abstract# 210 Poster Board #‐Session: P57‐I (2000) (1)
PRIMARY LIVER TRANSPLANTATION UNDER TACROLIMUS IN INFANTS, CHILDREN, ADULTS AND SENIORS: 1000 CONSECUTIVE PATIENTS FROM SINGLE CENTRE WITH 5 TO 8 YEARS ACTUAL FOLLOW-UP (1998) (1)
Adults transplanted as children as retransplant candidates: Analysis of outcomes support optimism in a population mislabeled as high risk (2020) (1)
WEANING OF IMMUNOSUPPRESSION IN LONG-TERM LIVER TRANSPLANT RECIPmNTS1,2 (1995) (1)
PEDIATRIC LIVER RESOURCE UTILIZATION-CURRENT INEQUITIES AND POSSIBLE SOLUTIONS. A REVIEW OF THE UNOS SCIENTIFIC REGISTRY DATA-1991-1997 (1999) (1)
INCIDENCE, MANAGEMENT, AND OUTCOME OF SERIOUS PANCREATITIS FOLLOWING PEDIATRIC LIVER TRANSPLANTATION (1998) (1)
Adaptation of split liver grafts in pediatric patients (2001) (1)
IS-23 Rabbit anti-thymocyte (rATG) preconditioning and induction for pediatric Intestinal transplantation(International Session V) (2004) (1)
OXALOSIS: STRATIFYING DISEASE SEVERITY AND THE ROLE OF ORGAN TRANSPLANTATION. (1998) (1)
197 Intestine Transplantation in Children (2012) (1)
184 Intestinal and Multiple Organ Transplantation (1)
PORTAL VERSUS SYSTEMIC VENOUS DRAINAGE OF INTESTINAL ALLOGRAFTS IN HUMANS (1998) (1)
Rejection of human intestinal allografts (1994) (1)
The PD-L1 Signal is Important to Liver Dendritic Cells in Induction of Foxp3+CD4+CD25+ Treg and Liver Transplant Tolerance (141.33) (2009) (1)
LIVER AND INTESTINE TRANSPLANTATION (1996) (1)
P254: Recipient and donor factors influence the incidence of graft versus host disease in liver transplant patients (2007) (1)
Mycophenolate mofetil for treatment of chronic rejection in liver allograft under tacrolimus. (2002) (1)
State of pediatric liver transplantation in the United States and achieving zero wait list mortality with ideal outcomes: A statement from the Starzl Network for Excellence in Pediatric Transplant Surgeon's Working Group (2022) (1)
Building a Utility-based Liver Allocation Model in Preparation for Continuous Distribution (2022) (1)
RIO Kinase 3 over Expression Promotes Hepatocellular Carcinoma Invasion through Induction of Epithelial- Mesenchymal Transition and a Potential Link to WNT/β-Catenin Pathway Activation (2014) (0)
Feasibility and Benefit of Minimization and Withdrawal of Immunosuppression (IS) Early After Liver Transplantation in HCV Positive Recipients.: Abstract# 2959 (2014) (0)
MONOSEGMENTAL BILE DUCT OCCLUSION AFTER SPLIT LIVER TRANSPLANTATION (1999) (0)
CLINICAL IMPACT OF TITRATED WITHDRAWAL OF IMMUNOSUPPRESSION IN PEDIATRIC LIVER TRANSPLANT RECIPIENTS (1998) (0)
Use of NanoICE for Procurement Achieves Better Cooling of Liver Grafts. (2017) (0)
IMMUNE MODULATION IN ORGAN RECIPIENTS BY SINGLE OR MULTIPLE DONOR BONE MARROW INFUSIONS (1998) (0)
Determinants of Failure in Hepatic Transplant. (2017) (0)
Assessing priorities and prognoses with prism scores in children receiving multiple (≥2) simultaneous abdomominal organ transplants (1999) (0)
Clinical intestinal transplantation: improved long-term survival (2000) (0)
RATE OF POST TRANSPLANT LYMPHO PROLIFERATIVEDISORDERS (PTLD) IN CHILDREN UNDER CYCLOSPORINE AND TACROLIMUS, 766 CONSECUTIVE RECIPIENTS: 15 YEARS EXPERIENCE.: Abstract# 787 Poster Board #‐Session: P44‐III (2000) (0)
Impact of Insurance Status on Outcomes of Children Undergoing Liver Transplantation (2019) (0)
Intestinal Transplantation. (1963) (0)
Epstein-Barr virus infection in pediatric small intestinal transplant patients (1997) (0)
LIVER TRANSPLANTATION AS TREATMENT FOR HEPATOCELLULAR MALIGNANCY IN CHILDREN. (1998) (0)
“Very early” intrahepatic cholangiocarcinoma may become an acceptable indication for liver transplantation. A multicenter validation study (2016) (0)
IS HISTADINE-TRYPTOPHAN-KETOGLUTARATE (HTK) BETTER THAN UNIVERSITY OF WISCONSIN (UW) SOLUTION FOR THE COLD PRESERVATION OF INTESTINAL AND MULTIVISCERAL ALLOGRAFTS? (2004) (0)
Donor procurement for intestinal transplantation (1997) (0)
Long-term efficacy of intestinal transplantation in patients with end stage gastrointestinal failure (1998) (0)
Cryptococcal meningitis causing blindness after liver transplantation. (1993) (0)
CLINICAL INTESTINAL TRANSPLANTATION IN CHILDREN (1998) (0)
Recent Advances in Hepatic Transplantation at (1993) (0)
RISK FOR EARLY DEMISE AMONG CHILDREN REFERRED FOR INTESTINAL TRANSPLANTATION (Itx): 124 (1997) (0)
Endoscopies in pediatric intestinal transplantation (1996) (0)
PANCREATIC TRANSPLANTATION IN ABDOMINAL VISCERAL RECIPIENTS: INDICATIONS, IMMUNOGENICITY AND FUNCTIONAL OUTCOME (2004) (0)
Inverse relationship between liver {gamma}{delta}T cells and Foxp3+CD25+CD4+ Tregs contributes to liver allograft tolerance and rejection (2009) (0)
CAUSES OF RETRANSPLANTATION, RATE AND SURVIVAL AFTER 4000 CONSECUTIVE PRIMARY LIVER TRANSPLANTATIONS FROM A SINGLE CENTER WITH 15 YEARS MEDIAN FOLLOWUP.: Abstract# 800 Poster Board #‐Session: P57‐III (2000) (0)
For Patients Listed for a Simultaneous Liver Kidney Transplants, the Use of DCD Organs Provides Significantly Inferior Liver Graft and Patient Survival, Similar to That of Transplantation of a Liver Allograft Alone.: Abstract# B1087 (2014) (0)
Serum Alkaline Phosphatase and Bilirubin Are Early Surrogate Markers for Ischemic Cholangiopathy and Graft Failure After DCD Liver Transplantation.: Abstract# B1090 (2014) (0)
Risk Factors Leading to Classification as Increased Risk (2016) (0)
Donor age still matters in liver transplantation. Results from the UNOS-SRTR database (2016) (0)
PEDIATRIC INTESTINAL TRANSPLANTATION: EVOLUTIONARY PROCESS (2004) (0)
POSTTRANSPLANT LYMPHOROLIFERATIVE DISORDERS (PTLD) IN INTESTINAL TRANSPLANT RECIPIENTS (2004) (0)
Allocation policies, logistics, and resource demands of living-related donor and split liver grafts: — the American experience (2002) (0)
I CHAPTER 185 Intestinal and Multiple Organ Transplantation (2010) (0)
HYPERBARIC OXYGEN THERAPY FOR HEPATIC ARTERY THROMBOSIS FOLLOWING PEDIATRIC LIVER TRANSPLANTATION (1998) (0)
Intestinal transplantation. (2006) (0)
INTESTINAL TRANSPLANTATION AND BONE MARROW AUGMENTATION.: Abstract# 754 Poster Board #‐Session: P11‐III (2000) (0)
Chapter 21. Small Bowel Transplantation in Children (2007) (0)
CLINICAL INTESTINAL TRANSPLANTATION: RISK FACTORS AND NEW STRATEGIES (1998) (0)
The Role of NKT Cells On Portal Tolerance Induction.: Abstract# D2789 (2014) (0)
Donor–Recipient BSA Matching Is Prognostically Significant in Solitary and En Bloc Kidney Transplantation From Pediatric Circulatory Death Donors (2021) (0)
Elevated immunoreactive trypsinogen levels in pediatric patients with short bowel syndrome. (1998) (0)
The role of liver NKT cells in the regulation of peripheral immune responses (42.9) (2007) (0)
Human hepatocyte transplantation for liver failure and mdtabolic defects (1996) (0)
THE INTERPLAY OF PD-L1 SIGNALING, γδ T AND T REGULATORY CELLS IN THE REGULATION OF ALLOGENEIC IMMUNE RESPONSE: 1628 (2010) (0)
Intestinal motility in children and adults after small bowel transplantation (1998) (0)
INTESTINAL TRANSPLANTATION FOR PATIENTS WITH VISCERAL VASCULAR OCCLUSIVE DISEASE (1999) (0)
LONG TERM IMPACT OF POSITIVE CROSSMATCH DUE TO IgG VERSUS IgM ANTIBODIES IN PRIMARY LIVER TRANSPLANTATION UNDER TACROLIMUS (1999) (0)
Small‐Bowel Transplantation in Children (2009) (0)
INTESTINAL TRANSPLANTATION.: Abstract# 98 (2000) (0)
Long-Term Renal Allograft Success : Realistic Goal or Idealistic Fantasy ? (2005) (0)
Intestinal and multivisceral transplantation: More than a decade of a single center experience0 (2003) (0)
Clinical Intestinal Transplantation in Children: Patient and Graft Survival and Rejection. (1999) (0)
For Patients Listed for Simultaneous Liver Kidney Transplants, Retransplantation Has Significantly Inferior Liver Graft and Patient Survival Compared to Primary Simultaneous Liver Kidney Transplantation.: Abstract# C1980 (2014) (0)
Pediatric liver transplantation: A Single Center Experience Spanning 20 Years1 (2002) (0)
NAT2 Genetic Polymorphism in Child Liver Disease. • 471 (1997) (0)
Pediatric Surgery and Urology: Intestinal and multivisceral transplantation (2006) (0)
A COMPARATIVE EVOLUTION OF EX-SITU AND IN-SITU SPLIT LIVER TRANSPLANTATION - THE PITTSBURGH EXPERIENCE (1999) (0)
LIVER DENDRITIC CELLS INDUCES FOXP3+ TREG AND LIVER GRAFT TOLERANCE IN A PD-L1 DEPENDENT MANNER: 1620 (2010) (0)
ISOLATED INTESTINAL TRANSPLANTATION (ISBTx) IN CHILDREN: A REAPPRAISAL: 125 (1997) (0)
Liver transplantation for hepatocellular carcinoma in children (2006) (0)
Donor CMV Reactivation as a Novel Risk Factor for CMV Replication in Seropositive Liver Transplant Recipients (2020) (0)
What's New in Pediatric Organ Transplantation (1999) (0)
130 SMALL BOWEL TRANSPLANTATION AS A CURE FOR CHRONIC INTESTINAL PSEUDO-OBSTRUCTION (CIPO). (1996) (0)
112Causes of retransplantation FTER 4000 consecutive primary liver transplantations from a single center with 15 years median followup rate and survival (2000) (0)
DIFFERENT FOXP3 EXPRESSING REGULATORY T CELLS IN THE LIVER CONTRIBUTE TO PORTAL TOLERANCE: 381 (2008) (0)
THE NEUROPATHOLOGY OF SMALL BOWEL TRANSPLANTATION (1998) (0)
Small Bowel Transplantation (2002) (0)
HEPATIC ARTERY COMPLICATION FOLLOWING PRIMARY LIVER TRANSPLANTATION IN ADULTS AND CHILDREN: 1000 CONSECUTIVE CASES UNDER TACROLIMUS (1999) (0)
For Pediatric Patients Listed for Simultaneous Liver-Kidney Transplantation, Those Who Received Both a Liver and a Kidney Transplant Had Significantly Better Graft and Patient Survival Than Those Who Received Only a Liver Transplant.: Abstract# C1989 (2014) (0)
INTESTINAL TRANSPLANTATION AND END STAGE GASTROINTESTINAL DISEASE: IMPROVED OUTCOME AND COST EFFECTIVENESS (1999) (0)
THE ROLE OF THE PD-L1 SIGNAL IN THE REGULATION OF ALLOGENEIC IMMUNE RESPONSE: 508 (2008) (0)
Repertoire, memory subsets, and function of EBV-specific CD8+T cells in peripheral blood from stable solid organ transplant patients (2003) (0)
CHRONIC REJECTION OF THE INTESTINAL ALLOGRAFT.: Abstract# 203 Poster Board #‐Session: P50‐I (2000) (0)
ABDOMINAL MULTIVISCERAL TRANSPLANTATION1,2 (2010) (0)
57 Bile duct complication following liver transplantation in adults and children: 1000 consecutives patients (2000) (0)
The Role of NKT Cells on Portal Tolerance Induction: 1529 (2012) (0)
CONCOMITANT INFUSION OF DONOR BONE MARROW TO ESTABLISH CHIMERISM AND TOLERANCE DOES NOT INCREASE THE RISK OF EBV ASSOCIATED LYMPHOMAS IN ORGAN ALLOGRAFT RECIPIENTS.: Abstract# 124 (2000) (0)
P0785 SINGLE CENTER EVOLUTIONARY EXPERIENCE IN PEDIATRIC INTESTINAL TRANSPLANTATION (2004) (0)
Dendritic Cells, Propagated From Bone Marrow With Low Dose GM-CSF, Expand FOXP3+ Regulatory T Cells and Prolong Heart Allograft Survival.: Abstract# B762 (2014) (0)
Functional analysis of graft lamina propria associated lymphocytes from a recipient of a human cadaveric small bowel allograft primarily immunosuppressed with FK 506. (1991) (0)
104Long term results of protocolized withdrawal of immunosuppression after liver transplantation (2000) (0)
110Causes of death after liver transplantation (LTx) in 4000 consecutive patients: Median followup 15 years (2000) (0)
Cytokine gene polymorphisms in children successfully withdrawn from immunosuppression after liver transplantation1 (2002) (0)
Immunosuppressant Strategies for Intestinal Transplantation: A Review of a Tolerogenic Regimen (2005) (0)
131Under cyclosporine and tacrolimus rate of post transplant lymphoproliferative disorders (PTLD) in children, 766 consecutive recipients: 15 Years experience (2000) (0)
LIVER DENDRITIC CELLS ARE POTENT INDUCERS OF REGULATORY T CELLS AND LIVER TRANSPLANT TOLERANCE: 295 (2008) (0)
Humoral graft versus host disease: Thrombocytopenia with antibodies to HLA and HPA (2005) (0)
Inverse relationship between liver γδT cells and Foxp3+CD25+CD4+ Tregs contributes to liver allograft tolerance and rejection (141.44) (2009) (0)
EXPANDING INDICATIONS FOR INTESTINAL TRANSPLANTATION (1999) (0)
Chapter 46 – Intestinal Transplantation (2005) (0)
Manipulating The Liver to Induce Systemic Tolerance to Heart Allografts Through CD4+CD25+ Regulatory T cells and NKT Cells (141.39) (2009) (0)
LONG TERM RESULTS OF PROTOCOLIZED WITHDRAWAL OF IMMUNOSUPPRESSION (IS) AFTER LIVER TRANSPLANTATION (LTX).: Abstract# 29 (2000) (0)
FK 506 in small bowel transplant recipients (1994) (0)
RAPAMYCIN RESCUE IN PEDIATRIC LIVER RECIPIENTS WITH TACROLIMUS TOXICITY.: Abstract# 211 Poster Board #‐Session: P58‐I (2000) (0)
PD-L1 Signal on Liver Dendritic Cells Is Critical for Foxp3+CD4+CD25+ Treg and Liver Tolerance Induction: 1551 (2012) (0)
Identifying Liver Transplant Candidates at Risk of Wait List Removal Due to Nonadherence Using a Quality-of-Life Survey: A Competing Risk Analysis. (2022) (0)
Gastric emptying in children with extreme short gut syndrome (1998) (0)
Angiotensin converting enzyme gene polymorphisms in pediatric liver transplant recipients (2004) (0)
Acute liver failure secondary to acute antibody mediated rejection after compatible liver transplant: A case report (2022) (0)
Using NanoICE for solid organ procurement provides better cooling physiology with improved preservation injury (2016) (0)
Whole Blood mRNA to Detect Hepatic Inflammation and Fibrosis in Post-Liver Transplant Patients With HCV.: Abstract# D2356 (2014) (0)
DRUG METABOLISM IN PEDIATRIC LIVER TRANSPLANTATION 199 (1997) (0)
Non-transplant Management of Portal Hypertension in Children (2017) (0)
EFFECT OF TRANSPLANTATION ON SMALL BOWEL MOTILITY (1997) (0)
INTESTINAL TRANSPLANTATION IN CHILDREN – 5 YEAR EXPERIENCE (1995) (0)
THE INVOLVEMENT OF GAMMA-DELTA T LYMPHOCYTES IN LIVER TRANSPLANT TOLERANCE: 2212 (2008) (0)

This paper list is powered by the following services:

Other Resources About Jorge D. Reyes

en.wikipedia.org

What Schools Are Affiliated With Jorge D. Reyes?

Jorge D. Reyes is affiliated with the following schools:

Jorge D. Reyes's Academic­Influence.com Rankings

Jorge D. Reyes's Degrees

Why Is Jorge D. Reyes Influential?

Jorge D. Reyes's Published Works

Published Works

Other Resources About Jorge D. Reyes

What Schools Are Affiliated With Jorge D. Reyes?

Jorge D. Reyes's AcademicInfluence.com Rankings